Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Change in Account Payables (2017 - 2025)

Catheter Precision (VTAK) has disclosed Change in Account Payables for 9 consecutive years, with $303000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Account Payables rose 354.62% to $303000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $186000.0, a 160.78% increase, with the full-year FY2024 number at -$234000.0, up 57.45% from a year prior.
  • Change in Account Payables was $303000.0 for Q3 2025 at Catheter Precision, up from -$49000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $921000.0 in Q3 2023 to a low of -$550000.0 in Q4 2023.
  • A 5-year average of -$19578.9 and a median of -$49000.0 in 2025 define the central range for Change in Account Payables.
  • Peak YoY movement for Change in Account Payables: crashed 544.74% in 2022, then soared 3511.11% in 2023.
  • Catheter Precision's Change in Account Payables stood at $456000.0 in 2021, then plummeted by 176.97% to -$351000.0 in 2022, then tumbled by 56.7% to -$550000.0 in 2023, then grew by 13.09% to -$478000.0 in 2024, then skyrocketed by 163.39% to $303000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Change in Account Payables are $303000.0 (Q3 2025), -$49000.0 (Q2 2025), and $410000.0 (Q1 2025).